Advances in In Vitro Vascularization of Engineered Tissues: From Microvessel Formation to Hepatic Tissue Integration. [PDF]
Huang YH, Ono A, Sudo R.
europepmc +1 more source
The Role of Neutrophils and NETosis in Diseases: The Implications for Therapy
Neutrophils secrete cytokines, express specific surface proteins, increase or decrease in cell count, and their ratio to lymphocyte count can be used as biomarkers to characterize collective status and disease progression. Neutrophils can monitor and track the body's health status, “Wei Bing” status, disease status, and different times of disease ...
Zhen Ma +6 more
wiley +1 more source
Theranostic Advancements in Brain Cancer: Promising Approaches for Emerging Therapy
Strategies for improving intra‐arterial administration (A) and photodynamic therapy in brain cancer (B). Improving intra‐arterial (IA) administration and photodynamic therapy (PDT) for brain cancer involves enhancing tumor targeting and breaching the blood–brain barrier (BBB). Key strategies include super selective catheterization, using osmotic agents
Bipraban Khanra, Manoj Kumar Sarangi
wiley +1 more source
Involvement of the Endothelial <i>N</i>-Methyl-d-Aspartate Receptor on Vessel-Associated Positioning and Differentiation of Cortical Oligodendrocytes and on Motor Activity. [PDF]
Beranger A +15 more
europepmc +1 more source
Cyclic changes in intramyocardial blood volume (iMBV) from systole to diastole can mark coronary disease without the need for vasodilator stress. We present a ferumoxytol‐enhanced MRI technique using a new continuous pulse sequence that effectively tracks cyclic myocardial T1 changes.
Hazar Benan Unal +8 more
wiley +1 more source
A tissue-engineered endothelial cell - smooth muscle cell arteriole-like model.
Zhu N +4 more
europepmc +1 more source
The diagnostic value of magnifying endoscopy with blue light imaging in early gastric cancer. [PDF]
Ye L, Yi X, Xiao X.
europepmc +1 more source
ABSTRACT Background Further work is needed to improve treatment outcomes for prostate cancer (PCa), with the repurposing of the α1‐adrenoreceptor antagonists presenting a potential solution. This feasibility clinical trial presents the first prospective data of the use of an α1‐adrenoreceptor antagonist in men undergoing radiotherapy for PCa.
Liam D. King +8 more
wiley +1 more source
Increased neurotoxic gliosis and blood-brain barrier dysregulation in canine cognitive dysfunction syndrome (CCD). [PDF]
Boland SW +5 more
europepmc +1 more source
ABSTRACT Bone restoration is often hindered by the spatiotemporal dysregulation of immune and regenerative signals. Conventional bio‐inert implants, providing only passive support, fail to modulate this microenvironment, leading to infections and poor healing.
Zhizhong Sun +8 more
wiley +1 more source

